The presence of an operational classification of drug interactions (ORCA) class 3 or 4 drug-drug interactions (DDIs) did not increase the risk for colchicine-related gastrointestinal adverse events or ... Please provide your email address to receive an email when new articles are posted on . More than 25% of patients with gout who use colchicine prophylaxis were on potentially interacting medications.

Understanding the Context

NEW YORK — New insights into colchicine's disruption of the pathway that contributes to arterial inflammation and new clinical studies of the drug could pave the way toward greater use of the ... Healio: Colchicine curbs cardiovascular event risk when used with urate-lowering therapy for gout Please provide your email address to receive an email when new articles are posted on . Patients taking colchicine had a weighted hazard ratio of 0.82 (95% CI, 0.69-0.94) for cardiovascular events. Colchicine curbs cardiovascular event risk when used with urate-lowering therapy for gout Renal & Urology News: Colchicine Prophylaxis for Gout Flares May Necessitate an Individualized Approach Patients with gout are commonly prescribed colchicine prophylaxis, despite already taking medications that could potentially interact.

Key Insights

Patients with gout are commonly prescribed colchicine prophylaxis ...